Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Volume 13, Number 1—January 2007

Research

Prevalence of G2P[4] and G12P[6] Rotavirus, Bangladesh

Mustafizur Rahman*†Comments to Author , Rasheda Sultana*, Giasuddin Ahmed*, Sharifun Nahar*, Zahid M. Hassan*, Farjana Saiada*, Goutam Podder*, Abu S. G. Faruque*, A. K. Siddique*, David A. Sack*, Jelle Matthijnssens†, Marc Van Ranst†, and Tasnim Azim*
Author affiliations: *International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh; †University of Leuven, Leuven, Belgium;

Main Article

Figure 2

Distribution of rotavirus-positive patients by month, Dhaka and Matlab, Bangladesh. Percentages of positive rotavirus patients were calculated based on all diarrhea patients admitted to the Dhaka and Matlab hospital surveillance system during 2001–2005. The years are shown with different colored lines. The thick brown line represents the average for all years.

Figure 2. Distribution of rotavirus-positive patients by month, Dhaka and Matlab, Bangladesh. Percentages of positive rotavirus patients were calculated based on all diarrhea patients admitted to the Dhaka and Matlab hospital surveillance system during 2001–2005. The years are shown with different colored lines. The thick brown line represents the average for all years.

Main Article

Top of Page

 

Past Issues

Select a Past Issue:

World Malaria Day - April 25, 2014 - Invest in the future, defeat malaria

20th Anniversary - National Infant Immunization Week - Immunization. Power to Protect.

Art in Science - Selections from Emerging Infectious Diseases
Now available for order



CDC 24/7 – Saving Lives, Protecting People, Saving Money. Learn More About How CDC Works For You…

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO